Precision BioSciences, Inc.
DTIL
$7.43
$0.131.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.83% | 10.33% | 213.46% | -32.55% | -171.82% |
| Total Depreciation and Amortization | -13.36% | -9.22% | -10.44% | -33.33% | -49.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 208.77% | 457.30% | -86.75% | 1,093.20% | 214.22% |
| Change in Net Operating Assets | 200.38% | -352.20% | -3,120.31% | -80.96% | 94.11% |
| Cash from Operations | 33.69% | 37.35% | 39.78% | -158.29% | -36.33% |
| Capital Expenditure | 100.00% | 71.88% | 80.41% | 100.00% | 92.86% |
| Sale of Property, Plant, and Equipment | -80.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 60.00% | -- | 100.00% | -- |
| Cash from Investing | 108.33% | 63.69% | -235.05% | 126.56% | 57.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -93.03% | 1,204.98% | -55.76% | 654.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -93.03% | 1,209.39% | -55.56% | 654.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.29% | -30.27% | 612.76% | -506.06% | -5.55% |